HSBC Holdings plc set a €65.00 ($76.47) price objective on Gerresheimer AG (ETR:GXI) in a research note issued to investors on Tuesday morning. The brokerage currently has a neutral rating on the stock.
Several other research firms have also issued reports on GXI. Independent Research GmbH set a €78.00 ($91.76) price target on Gerresheimer AG and gave the company a neutral rating in a research report on Wednesday, July 19th. DZ Bank AG reissued a buy rating on shares of Gerresheimer AG in a research report on Monday, July 17th. Deutsche Bank AG set a €82.00 ($96.47) price target on Gerresheimer AG and gave the company a buy rating in a research report on Friday, July 7th. Berenberg Bank set a €75.00 ($88.24) price target on Gerresheimer AG and gave the company a buy rating in a research report on Wednesday, October 11th. Finally, Kepler Capital Markets set a €70.00 ($82.35) target price on Gerresheimer AG and gave the stock a sell rating in a research report on Thursday, July 13th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of €73.14 ($86.05).
Gerresheimer AG (ETR GXI) opened at 66.505 on Tuesday. The firm has a market capitalization of €2.09 billion and a PE ratio of 18.422. Gerresheimer AG has a one year low of €59.97 and a one year high of €79.47. The stock has a 50 day moving average of €64.78 and a 200-day moving average of €70.18.
About Gerresheimer AG
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.